These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38215898)

  • 21. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
    Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
    Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive assessment of deep generative architectures for de novo drug design.
    Wang M; Sun H; Wang J; Pang J; Chai X; Xu L; Li H; Cao D; Hou T
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34929743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Faster and more diverse de novo molecular optimization with double-loop reinforcement learning using augmented SMILES.
    Bjerrum EJ; Margreitter C; Blaschke T; Kolarova S; de Castro RL
    J Comput Aided Mol Des; 2023 Aug; 37(8):373-394. PubMed ID: 37329395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UnCorrupt SMILES: a novel approach to de novo design.
    Schoenmaker L; Béquignon OJM; Jespers W; van Westen GJP
    J Cheminform; 2023 Feb; 15(1):22. PubMed ID: 36788579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep generative models for ligand-based de novo design applied to multi-parametric optimization.
    Perron Q; Mirguet O; Tajmouati H; Skiredj A; Rojas A; Gohier A; Ducrot P; Bourguignon MP; Sansilvestri-Morel P; Do Huu N; Gellibert F; Gaston-Mathé Y
    J Comput Chem; 2022 Apr; 43(10):692-703. PubMed ID: 35218219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.
    Monteiro NRC; Pereira TO; Machado ACD; Oliveira JL; Abbasi M; Arrais JP
    Comput Biol Med; 2023 Sep; 164():107285. PubMed ID: 37557054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-Adversarial Learning for Molecular Generation in Drug Design.
    Wu B; Li L; Cui Y; Zheng K
    Front Pharmacol; 2021; 12():827606. PubMed ID: 35126153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Cloud Computing Platform for Scalable Relative and Absolute Binding Free Energy Predictions: New Opportunities and Challenges for Drug Discovery.
    Lin Z; Zou J; Liu S; Peng C; Li Z; Wan X; Fang D; Yin J; Gobbo G; Chen Y; Ma J; Wen S; Zhang P; Yang M
    J Chem Inf Model; 2021 Jun; 61(6):2720-2732. PubMed ID: 34086476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pharmacophore-guided deep learning approach for bioactive molecular generation.
    Zhu H; Zhou R; Cao D; Tang J; Li M
    Nat Commun; 2023 Oct; 14(1):6234. PubMed ID: 37803000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equivariant score-based generative diffusion framework for 3D molecules.
    Zhang H; Liu Y; Liu X; Wang C; Guo M
    BMC Bioinformatics; 2024 May; 25(1):203. PubMed ID: 38816718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular substructure tree generative model for de novo drug design.
    Wang S; Song T; Zhang S; Jiang M; Wei Z; Li Z
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35039853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing interactions to protein binding sites by integrating docking-scoring strategies into generative AI methods.
    Sauer S; Matter H; Hessler G; Grebner C
    Front Chem; 2022; 10():1012507. PubMed ID: 36339033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
    Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
    J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping of Protein Binding Sites using clustering algorithms - Development of a pharmacophore based drug discovery tool.
    Braun J; Fayne D
    J Mol Graph Model; 2022 Sep; 115():108228. PubMed ID: 35667141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Library design using BCUT chemistry-space descriptors and multiple four-point pharmacophore fingerprints: simultaneous optimization and structure-based diversity.
    Mason JS; Beno BR
    J Mol Graph Model; 2000; 18(4-5):438-51, 538. PubMed ID: 11143561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining Cloud-Based Free-Energy Calculations, Synthetically Aware Enumerations, and Goal-Directed Generative Machine Learning for Rapid Large-Scale Chemical Exploration and Optimization.
    Ghanakota P; Bos PH; Konze KD; Staker J; Marques G; Marshall K; Leswing K; Abel R; Bhat S
    J Chem Inf Model; 2020 Sep; 60(9):4311-4325. PubMed ID: 32484669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
    Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
    Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacophore based drug design approach as a practical process in drug discovery.
    Gao Q; Yang L; Zhu Y
    Curr Comput Aided Drug Des; 2010 Mar; 6(1):37-49. PubMed ID: 20370694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform.
    Desai B; Dixon K; Farrant E; Feng Q; Gibson KR; van Hoorn WP; Mills J; Morgan T; Parry DM; Ramjee MK; Selway CN; Tarver GJ; Whitlock G; Wright AG
    J Med Chem; 2013 Apr; 56(7):3033-47. PubMed ID: 23441572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.